Welcome to our dedicated page for MUSTGROW BIOLOGICS news (Ticker: MGROF), a resource for investors and traders seeking the latest updates and insights on MUSTGROW BIOLOGICS stock.
MustGrow Biologics Corp (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0), based in Saskatoon, develops organic biocontrol and biofertility products using mustard plant's natural defense mechanism. The company has a collaboration agreement with Bayer AG for mustard-based biocontrol technologies. MustGrow's TerraSanteTM is an organic biofertility product focusing on soil health, nutrient efficiency, and plant yields, recently approved for sales in Oregon, Washington, and California. With sustainable solutions for preplant soil treatment, weed control, and postharvest disease, MustGrow aims to revolutionize crop protection for global food sustainability.
News
Rhea-AI Summary
MustGrow Biologics Corp. has received approval from Health Canada's Pest Management Regulatory Agency to begin large-scale field trials for its TerraMG™ mustard-derived soil biopesticide technology. The trials will focus on Canadian canola and pulse crop markets as part of NexusBioAg's 2024 BioAdvantage Trials Program. This program will evaluate the efficacy and commercial potential of TerraMGTM.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
News
Rhea-AI Summary
MustGrow Biologics Corp. has received organic compliance certification from the USDA National Organic Program for its TerraSanteTM crop fertilizer and soil amendment technology. The organic certification may provide an opportunity for farmers to reduce synthetic chemical and fertilizer use while meeting growing market demand for organic biological products. MustGrow plans to continue advancing its TerraSanteTM registration approval process in key U.S. states.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32.63%
Tags
-
Rhea-AI Summary
MustGrow Biologics Corp. to participate in the Annual Biocontrol Industry Meeting in Switzerland
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.51%
Tags
Rhea-AI Summary
MustGrow Biologics engages Harbor Access for investor relations services, aiming to expand investor base and create wider awareness. MustGrow will pay a cash fee of USD$8,000 per month for 12 months.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
MustGrow and Janssen PMP expand their exclusive agreement to include postharvest potatoes and bananas globally, strengthening their partnership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.43%
Tags
-
Rhea-AI Summary
MustGrow Biologics Corp. authorized the grant of 612,757 DSUs and 177,035 RSUs to directors, officers, and consultants. RSUs will vest on March 28, 2024. DSUs will vest immediately upon grant.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
MustGrow Biologics Corp. has won the 'AgTech Innovation of the Year' award in the 4th annual AgTech Breakthrough Awards program. MustGrow focuses on developing natural biological technologies and products from mustard seed for sustainable agriculture markets. Their technology platform offers natural defense mechanisms against diseases and pests, as well as proteins and carbohydrates that feed soil microbes. The company's biologics have the potential to replace synthetic chemicals and fertilizers, while promoting soil health and fertility. MustGrow's technology is safe, non-hazardous, and can be used in organic production.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
-
Rhea-AI Summary
MustGrow Biologics Corp. announces results of its 2023 annual meeting of shareholders. Shareholders approved the number of directors at seven and elected all director nominees. Shareholders also reappointed auditors and approved the Omnibus Plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.9%
Tags
FAQ
What is the current stock price of MUSTGROW BIOLOGICS (MGROF)?
The current stock price of MUSTGROW BIOLOGICS (MGROF) is $1.11 as of January 8, 2025.
What is the market cap of MUSTGROW BIOLOGICS (MGROF)?
The market cap of MUSTGROW BIOLOGICS (MGROF) is approximately 64.6M.
What is MustGrow Biologics Corp focused on?
MustGrow focuses on developing organic biocontrol and biofertility products using the mustard plant's natural defense mechanism to protect the global food supply sustainably.
What is TerraSanteTM?
TerraSanteTM is an organic biofertility product by MustGrow, focusing on soil microbiome health, nutrient/water use efficiencies, and plant yields.
Which regions have approved the sales of TerraSanteTM?
TerraSanteTM has been approved for sales in Oregon, Washington, and California, making it available for use in those states.
What collaborations does MustGrow have?
MustGrow collaborates with global partners like Bayer, Janssen PMP, Sumitomo Corporation, and Univar Solutions' NexusBioAg to develop mustard-based organic solutions for biocontrol applications.
What milestones has MustGrow achieved recently?
MustGrow recently announced a collaboration agreement with Bayer AG for mustard-based biocontrol technologies and the approval of its TerraSanteTM in multiple U.S. states.
MUSTGROW BIOLOGICS CORP
OTC:MGROF
MGROF Rankings
MGROF Stock Data
64.55M
44.31M
10.78%
Agricultural Inputs
Basic Materials
United States of America
Saskatoon